Robert C. Moscato, Jr
2018 - Avalo Therapeutics
In 2018, Robert C. Moscato, Jr earned a total compensation of $270.7K as Former President, Chief Operating Officer and Director at Avalo Therapeutics, a 983% increase compared to previous year.
Compensation breakdown
| Salary | $70,685 |
|---|---|
| Other | $200,000 |
| Total | $270,685 |
Moscato received $200K in other compensation, accounting for 74% of the total pay in 2018.
Moscato also received $70.7K in salary.
Rankings
In 2018, Robert C. Moscato, Jr's compensation ranked 13,340th out of 14,244 executives tracked by ExecPay. In other words, Moscato earned more than 6.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,340 out of 14,244 | 6th |
Division Manufacturing | 5,410 out of 5,765 | 6th |
Major group Chemicals And Allied Products | 2,021 out of 2,128 | 5th |
Industry group Drugs | 1,735 out of 1,817 | 5th |
Industry Pharmaceutical Preparations | 1,326 out of 1,391 | 5th |
Source: SEC filing on June 19, 2019.
Moscato's colleagues
We found six more compensation records of executives who worked with Robert C. Moscato, Jr at Avalo Therapeutics in 2018.
2018
Peter Greenleaf
Avalo Therapeutics
Chief Executive Officer
2018
Mariam Morris
Avalo Therapeutics
Chief Financial Officer
2018
Joseph Miller
Avalo Therapeutics
Chief Financial Officer
2018
James Harrell
Avalo Therapeutics
Executive Vice President, Marketing and External Communications
2018
Pericles Calias
Avalo Therapeutics
Chief Scientific Officer
2018
Simon Pedder
Avalo Therapeutics